PHI with Hepatic encephalopathy
How does this condition affect your private health insurance?
Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome arising from severe liver dysfunction, where the liver fails to detoxify blood effectively. Toxins, primarily ammonia, accumulate and cross the blood-brain barrier, affecting brain function. Manifestations range from subtle cognitive impairments like forgetfulness, impaired concentration, and personality changes to severe confusion, disorientation, lethargy, and coma. Triggers often include gastrointestinal bleeding, infections, dehydration, or electrolyte imbalances, particularly in patients with cirrhosis or acute liver failure. HE significantly impacts quality of life and prognosis. Prompt diagnosis, identification of triggers, and medical management, including lactulose and rifaximin, are essential to control symptoms and prevent progression to life-threatening stages. Recurrence is common without continuous management of the underlying liver disease.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Days to several weeks, depending on severity and response to treatment.
Duration of Illness (Lifetime)
Often chronic and recurrent, especially in the context of persistent underlying liver disease (e.g., cirrhosis). May require ongoing management.
Cost of Treatment (Initial)
Typically ranges from $5,000 to $30,000 USD for an acute hospitalization, including diagnostics and initial medications.
Cost of Treatment (Lifetime)
Can range from $50,000 to over $500,000 USD, especially with recurrent episodes, long-term medication, and potential need for liver transplant evaluation.
Mortality Rate
Varies significantly with severity and underlying liver condition; ranges from 10-20% for acute episodes to over 50% in severe cases or acute liver failure without transplant.
Risk of Secondary Damages
High, including persistent cognitive impairment, neurological deficits, reduced quality of life, increased risk of falls, and functional decline.
Probability of Full Recovery
Moderate to low for complete, sustained recovery without recurrence, especially in chronic liver disease. Recovery from an acute episode is possible, but recurrence is common if underlying liver disease is not managed.
Underlying Disease Risk
Very high (nearly 100%), as it is a complication of severe underlying liver diseases such as cirrhosis (from various causes like alcohol, viral hepatitis, NAFLD) or acute liver failure.